| Literature DB >> 15243998 |
Margaret Crawford1, Rob Woodman, Paul Ko Ferrigno.
Abstract
Peptide aptamer technology is relatively youthful. It has the advantage over existing techniques that the reagents identified are designed for expression in eukaryotic cells. This allows the construction of molecular tools that allow the logic of genetics, from knockouts to extragenic suppressors, to be applied to studies of proteins in tissue culture cells. Until recently, the available tools have limited our understanding of cell biology. The same limitation restricts out ability to validate the numerous candidate drug targets emerging from genome-wide approaches to cellular biology. Peptide aptamers represent a stride forwards in the evolution of a modular, molecular tool kit for cell biology and for drug target validation. The authors predict that they will also play a role in the transition from genomic to proteomic microarray technology.Mesh:
Substances:
Year: 2003 PMID: 15243998 DOI: 10.1093/bfgp/2.1.72
Source DB: PubMed Journal: Brief Funct Genomic Proteomic ISSN: 1473-9550